%0 Journal Article
%T Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
%A Girardin F
%A Manuel O
%A Marzolini C
%A Buclin T
%A Girardin F
%A Manuel O
%A Marzolini C
%A Buclin T
%A Girardin F
%A Manuel O
%A Marzolini C
%A Buclin T
%J Clin Microbiol Infect
%V 28
%N 8
%D Aug 2022
%M 35358684
%F 13.31
%R 10.1016/j.cmi.2022.03.030
%X